To include your compound in the COVID-19 Resource Center, submit it here.

Adefovir dipivoxil: Phase III

GILD said that in a subset of 131 post-liver transplant, lamivudine-resistant chronic hepatitis B virus (HBV) patients in an international 230-patient open-label Phase III trial (Study 435), 10 mg of Adefovir

Read the full 310 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE